Blog

Victoza (generic: liraglutide) was approved by the U.S. Food and Drug Administration (FDA) to serve as a once-daily injection for the treatment of type 2 diabetes in some adults. Of significant concern, however, are the serious side effects that have recently been associated with clinically relevant Victoza exposure. Subsequently, Victoza treatment may place patients…

Recent years have witnessed several antidepressant medications become the subject of increasingly critical skepticism. Compounding the criticism further are reports of new evidence that lends weight tot he long-suspected link between selective serotonin reuptake inhibitors (SSRIs) and congenital birth defects. According to a new study, the risk of a child developing persistent pulmonary hypertension…

The U.S. Food & Drug Administration (FDA) has recently strengthened their initial warning on the drug Topamax (generic: topiramate). Previously, the Topamax medication was assigned to the Pregnancy Category C because of a lack of human data. However, they strengthened the warning to Category D as a direct result of new data that suggests…

Recent years have witnessed an influx of manufacturers incorporate active pharmaceutical ingredients into the development of dietary supplements. Accordingly, their actions suggest an attempt at increasing results without the hassles that accompany U.S. Food and Drug Administration (FDA) regulations. However, transgressions such as these are not only in violation of the Federal Food, Drug,…

Reumofan Plus is touted as an all-natural dietary supplement that is administered in the treatment of arthritis, muscle pain, osteoporosis, bone cancer, and other conditions. However, a lab analysis conducted by the U.S. Food and Drug Administration (FDA) confirmed the presence of three undisclosed and potentially dangerous prescription drug ingredients in Reumofan Plus tablets….

In continuing with a recent global trend, several prominent healthcare regulatory agencies have begun to publicly express their concern regarding dietary supplements that contain DMAA. The most recent of which are Australian authorities who have warned consumers of the increased propensity for severe side effects that may coincide with the use of sports supplements…

Earlier this week, officials at the U.S. Food and Drug Administration (FDA) ordered a revision of the labels on Yaz, Yasmin and Beyaz products. Subsequently, the revision is to include an expanded warning section that acknowledges their association with the development of blood clots. Furthermore, these clots have served as a catalyst for litigation…

The majority of dietary supplements, including those of the weight loss and fitness variety, are marketed as shortcuts for those looking to enhance certain aspects of their body. However, recent years have witnessed an exponential increase in the transgressions committed by dietary supplement manufacturers. Of significant concern, is the onslaught of unsubstantiated claims made…